News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight Yael L. Maxwell June 16, 2022